Stay tuned and follow the latest
developments and news in Molecular Oncology.
Following the presentation of the ALASCCA trial at ASCO GI 2025, aspirin has emerged as a promising adjuvant therapy in patients with stage II–III colorectal cancer (CRC) harboring PI3K pathway […]
Viac
We are pleased to share the latest publication featuring Prime DX in the International Journal of Molecular Sciences „Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use” […]
Viac
With great joy and pride, we announce that Genekor Medical S.A. has officially received accreditation from the College of American Pathologists (CAP), one of the world’s leading organisations for the […]
Viac
#DressinBlueDay Wearing blue this month has a special meaning for us at GeneKor. Blue is the color of support for those affected by colorectal cancer, one of the most common […]
Viac
NICE diagnostics guidance – evaluation of effectiveness and efficiency The NICE (National Institute for Health and Care Excellence) diagnostics guidance DG58 givesevidence-based recommendations to guide treatment decisions and evaluate the […]
Viac
This year, our team attended the San Antonio Breast Cancer Symposium (SABCS) in Texas, a key event in breast cancer research. It was a great opportunity to connect with healthcare […]
Viac
Source: Iatronet Nikolaos Tsoulos, MBA, PhD, Molecular Biochemist, CEO of GeneKor Medical SA, and Chairman of the Hellenic Society of Diagnostic Laboratories (EDEM), spoke to Iatronet about accredited diagnostic laboratories […]
Viac
The FRα test is performed for the administration of mirvetuximab soravtansine and is aimed at patients with platinum-resistant ovarian cancer who are FRα-positive and have received 1-3 lines of therapy. […]
Viac